Presentation of the second quarter 2017

Biotec Pharmacon ASA (”Biotec”, OSE: BIOTEC) reported sales of NOK 16.4 million (15.3) in the second quarter of 2017, and a negative EBITDA of NOK 4.4 million (-1.6). Woulgan® generated sales of NOK 0.9, up from NOK 0.4 million in the first quarter of 2017 . ArcticZymes continued its positive sales growth and reported NOK 8.4 million in sales, an 8 percent increase from the second quarter of 2016.


Presentation of the second quarter 2017

Presentation of the first quarter 2017

Presentation of the fourth quarter 2016

Presentation of the third quarter 2016

Presentation of the second quarter 2016

Presentation of the first quarter 2016

Presentation of the fourth quarter 2014

Presentation of the third quarter 2014

Presentation of the second quarter 2014

Presentation of the first quarter 2014

Presentation of the fourth quarter

Presentation of the third quarter

Presentation of the second quarter

Presentation of the first quarter

Presentation of the fourth quarter

Presentation of the third quarter

Presentation of the second quarter

Presentation of the first quarter

Presentation of the fourth quarter

Presentation of the third quarter

Presentation of the second quarter

Presentation of the first quarter

Presentation of the fourth quarter

Presentation of the third quarter

Presentation of the second quarter

Presentation of the first quarter

Presentation of the fourth quarter

Presentation of the third quarter

Presentation of the second quarter

Presentation of the first quarter

Presentation of the fourth quarter

Presentation of the third quarter

Presentation of the second quarter

Presentation of the first quarter

Presentation of the fourth quarter

Presentation of the third quarter

Presentation of the second quarter

Presentation of the first quarter

Presentation of the fourth quarter

Presentation of the third quarter

Presentation of the first quarter

Presentation of the fourth quarter

Presentation of the third quarter